THE RISK OF MYOCARDIAL-INFARCTION ASSOCIATED WITH ANTIHYPERTENSIVE DRUG THERAPIES

被引:866
|
作者
PSATY, BM
HECKBERT, SR
KOEPSELL, TD
SISCOVICK, DS
RAGHUNATHAN, TE
WEISS, NS
ROSENDAAL, FR
LEMAITRE, RN
SMITH, NL
WAHL, PW
WAGNER, EH
FURBERG, CD
机构
[1] UNIV WASHINGTON, DEPT EPIDEMIOL, SEATTLE, WA 98101 USA
[2] UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98101 USA
[3] UNIV WASHINGTON, DEPT HLTH SERV, SEATTLE, WA 98101 USA
[4] UNIV MICHIGAN, SURVEY RES CTR, INST SOCIAL RES, ANN ARBOR, MI USA
[5] LEIDEN UNIV HOSP, DEPT CLIN EPIDEMIOL, LEIDEN, NETHERLANDS
[6] CTR HLTH STUDIES, GRP HLTH COOPERAT PUGET SOUND, SEATTLE, WA USA
[7] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT PUBL HLTH SCI, WINSTON SALEM, NC 27103 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1995年 / 274卷 / 08期
关键词
D O I
10.1001/jama.274.8.620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To assess the association between first myocardial infarction and the use of antihypertensive agents. Design and Setting.-We conducted a population-based case-control study among enrollees of the Group Health Cooperative of Puget Sound (GHC). Patients and Methods.-Cases were hypertensive patients who sustained a first fatal or nonfatal myocardial infarction from 1986 through 1993 among women and from 1989 through 1993 among men. Controls were a stratified random sample of hypertensive GHC enrollees, frequency matched to the cases on age, sex, and calendar year, All 623 cases and 2032 controls had pharmacologically treated hypertension. Data collection included a review of the ambulatory medical record and a brief telephone interview of consenting survivors. Antihypertensive therapy was assessed using the GHC's computerized pharmacy database. Results.-The first analysis included only the 335 cases and 1395 controls initially free of cardiovascular disease. Compared with users of diuretics alone, the adjusted risk ratio of myocardial infarction was increased by about 60% among users of calcium channel blockers with or without diuretics (risk ratio=1.62; 95% confidence interval [CI], 1.11 to 2.34; P=.01). The second analysis was restricted to 384 cases and 1108 controls who were taking either a calcium channel blocker or a beta-blocker. Among these subjects, the use of calcium channel blockers compared with beta-blockers was associated with about a 60% increase in the adjusted risk of myocardial infarction (risk ratio=1.57; 95% CI, 1.21 to 2.04; P<.001). While high doses of beta-blockers were associated with a decreased risk of myocardial infarction (trend P=.04), high doses of calcium channel blockers were associated with an increased risk (trend P<.01). Conclusions.-In this study of hypertensive patients, the use of short-acting calcium channel blockers, especially in high doses, was associated with an increased risk of myocardial infarction. Ongoing targe-scale clinical trials will assess the effect of various antihypertensive therapies, including calcium channel blockers, on several important cardiovascular end points. Until these results are available, the findings of this study support the current guidelines from the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure that recommend diuretics and beta-blockers as first-line agents unless contraindicated, unacceptable; or not tolerated.
引用
收藏
页码:620 / 625
页数:6
相关论文
共 50 条
  • [11] FAMILY HISTORY OF PREMATURE MYOCARDIAL-INFARCTION AND THE RISK OF NONFATAL MYOCARDIAL-INFARCTION
    OCONNOR, GT
    BURING, JE
    MOORE, LL
    GOLDHABER, SZ
    STAMPFER, MJ
    WILLETT, WC
    HENNEKENS, CH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 128 (04) : 916 - 916
  • [12] MAXIMIZING BENEFITS OF THERAPIES IN ACUTE MYOCARDIAL-INFARCTION
    LEFEUVRE, C
    YUSUF, S
    FLATHER, M
    FARKOUH, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (19): : G145 - G155
  • [13] MYOCARDIAL-INFARCTION ASSOCIATED WITH THYROTOXICOSIS
    HOSHINO, T
    AYA, S
    YAMAZAKI, H
    AYABE, T
    HANDA, S
    NAKAMURA, Y
    ZEITSCHRIFT FUR KARDIOLOGIE, 1978, 67 (02): : 99 - 103
  • [14] MYOCARDIAL-INFARCTION ASSOCIATED WITH THYROTOXICOSIS
    KOTLER, MN
    MICHAELIDES, KM
    BOUCHARD, RJ
    WARBASSE, JR
    ARCHIVES OF INTERNAL MEDICINE, 1973, 132 (05) : 723 - 728
  • [15] MYOCARDIAL-INFARCTION ASSOCIATED WITH ANESTHESIA
    HOVIVIANDER, M
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1981, 25 : 48 - 48
  • [16] MYOCARDIAL-INFARCTION ASSOCIATED WITH DEXTROFENFLURAMINE
    KENT, A
    LACEY, JH
    BRITISH MEDICAL JOURNAL, 1990, 301 (6759): : 1050 - 1050
  • [17] LIPOPROTEIN(A) AND RISK OF MYOCARDIAL-INFARCTION
    RITTER, MM
    GEISS, HC
    RICHTER, WO
    SCHWANDT, P
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (14): : 1077 - 1077
  • [18] A RISK OF HYPERTRIGLYCERIDEMIA FOR MYOCARDIAL-INFARCTION
    AGETA, M
    UCHIYAMA, S
    NONAKA, K
    UEKI, K
    TOSHIMA, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (08): : 756 - 757
  • [19] LIPOPROTEINS AND RISK OF MYOCARDIAL-INFARCTION
    ASSMANN, G
    FETTE SEIFEN ANSTRICHMITTEL, 1986, 88 (11): : 433 - 433
  • [20] RISK AFTER MYOCARDIAL-INFARCTION
    BOISSEL, JP
    PEYRIEUX, JC
    LEIZOROVICZ, A
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1986, 79 (04): : 559 - 559